HealthpointCapital, a private equity firm focused exclusively on musculoskeletal healthcare, announced a significant investment in Ospitek, Inc. on October 13, 2026. Ospitek was founded to address operational inefficiencies across surgical settings by delivering real-time visibility across the surgical episode of care. The company's platform enables healthcare facilities to optimize operations, enhance communication, and improve patient experiences.
Technology and Operational Intelligence
Ospitek's technology combines artificial intelligence, digital infrastructure, automation, and analytics to synchronize teams, automate communication, and generate real-time operational intelligence. This intelligence helps healthcare organizations identify inefficiencies, benchmark performance, and make data-driven decisions that improve patient throughput and operating room performance. The platform is designed to create transparency across the entire surgical journey for patients, surgeons, and staff.
Addressing Industry Pressures
Hospitals and surgery centers are laser-focused on driving efficiency while improving patient, surgeon, and staff satisfaction. Mike Mogul, Managing Partner of HealthpointCapital, said Ospitek gives all of those stakeholders a transparent and informative view of the surgical journey. The platform also enables significant improvements in care delivery capacity for each facility.
Executive Perspectives
Dr. Slim Souissi, Ph.D., Chief Executive Officer of Ospitek, stated that the partnership with HealthpointCapital will allow the company to accelerate innovation, expand capabilities, and bring its technology to more surgical facilities across the country. He described the future of surgery as connected, intelligent, predictive, and patient-centered. Ospitek is focused on helping build that future through continued product development and commercial growth.
Investment Plans and Market Opportunity
HealthpointCapital will support continued investment in Ospitek's technology platform, commercial organization, customer success capabilities, and product innovation. The company is well positioned to capitalize on the growing demand for workflow automation and operational intelligence solutions across ambulatory surgery centers, specialty hospitals, and broader healthcare settings. Along with HealthpointCapital's investment in SteriCUBE, a leading system for surgical equipment flow, this deal continues the firm's focus on platforms that enable healthcare facilities to scale effectively and efficiently.
Strategic Track Record
HealthpointCapital has a track record of notable exits in the musculoskeletal sector, including CrossRoads Extremity Systems, OrthoSpace, Blue Belt Technologies, and BioHorizons. These companies were acquired by Johnson & Johnson DePuy Synthes, Stryker, Smith+Nephew, and Henry Schein, respectively. The firm combines operating experience with an extensive network of clinical, commercial, and strategic relationships to support portfolio growth.
About HealthpointCapital
HealthpointCapital is led by Managing Partner Mike Mogul together with Matt Link, Milen Todorov, Gary Stevenson, Lisa Holt, and Bill Johnson. The firm brings extensive medical device operating experience, a strong private equity track record, and a broad network of clinical and commercial relationships to help portfolio companies accelerate growth. Its exclusive focus on musculoskeletal healthcare distinguishes the firm in the private equity market.
About Ospitek
Ospitek, Inc. provides artificial intelligence and Internet of Things powered surgical operations software. Its platform delivers real-time visibility across the entire patient journey and helps healthcare providers improve throughput, operating room utilization, and patient experience. The company serves ambulatory surgery centers, specialty hospitals, and broader healthcare organizations seeking to improve operational performance.
Transaction details were not disclosed, and McDermott Will & Schulte LLP provided legal counsel to HealthpointCapital. The investment reflects growing private equity interest in technologies that improve surgical efficiency, operating room utilization, and patient experience. By combining capital with operational expertise, the partnership aims to help surgical facilities scale effectively in a demanding healthcare environment.